NCT04826302

Brief Summary

This study evaluates the efficacy of a myofascial intervention as a technique within manual therapy in the treatment of clinical anxiety in adults. Half of the participants will receive a myofascial intervention program, while the other half will receive a sham myofascial intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
19 days until next milestone

Study Start

First participant enrolled

April 20, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2022

Completed
Last Updated

August 2, 2022

Status Verified

July 1, 2022

Enrollment Period

1.3 years

First QC Date

March 25, 2021

Last Update Submit

July 31, 2022

Conditions

Keywords

anxietymyofascial inductionmyofascial releasemanual therapyphysiotherapy

Outcome Measures

Primary Outcomes (1)

  • State-Trait Anxiety Inventory (STAI)

    It consists of a self-report to evaluate two independent concepts about anxiety: anxiety as a state ("in this moment") and anxiety as a trait ("in most cases"). Each of these subscales has a total of 20 items in a 4-point Likert response system according to intensity (0 = not at all; 3 = a lot). The total score in each of the subscales ranges from 0 to 60 points.

    Change from baseline (pre-treatment), immediately after myofascial intervention (intrasession), through study completion (an average of 1 month), 3 and 6 months follow-up

Secondary Outcomes (5)

  • Visual Analogue Scale (VAS)

    Change from baseline (pre-treatment), immediately after myofascial intervention (intrasession), through study completion (an average of 1 month), 3 and 6 months follow-up

  • Central Sensitization Inventory (CSI)

    Change from baseline (pre-treatment), through study completion (an average of 1 month), 3 and 6 months follow-up

  • General Health Questionnaire (GHQ-12)

    Change from baseline (pre-treatment), through study completion (an average of 1 month), 3 and 6 months follow-up

  • Patient Health Questionnaire (PHQ-15)

    Change from baseline (pre-treatment), through study completion (an average of 1 month), 3 and 6 months follow-up

  • Beck Depression Inventory (BDI)

    Change from baseline (pre-treatment), through study completion (an average of 1 month), 3 and 6 months follow-up

Study Arms (2)

Myofascial treatment

EXPERIMENTAL

4 sessions of myofascial intervention, 40 minutes per session, 1 session per week

Other: Myofascial treatment

Sham myofascial treatment

SHAM COMPARATOR

4 sessions of sham myofascial intervention, 40 minutes per session, 1 session per week

Other: Sham myofascial treatment

Interventions

40 minutes of myofascial intervention: 10 min in each of the following regions with the patient face up: * Thoracolumbar fascia and abdomen * C7-T4 and sternum * Suboccipital area * Temporary area

Myofascial treatment

40 minutes of sham myofascial intervention: 10 min in each of the following regions with the patient face up and with the contact of the physiotherapist through a towel and without any intention: * Thoracolumbar fascia and abdomen * C7-T4 and sternum * Suboccipital area * Temporary area

Sham myofascial treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be between 18 and 65 years old
  • Subjects with high levels of anxiety
  • Subjects who speak and understand Spanish correctly
  • Subjects without previous experience in myofascial treatment

You may not qualify if:

  • Subjects with a clinical history of cognitive impairment
  • Subjects with systemic, neurological or muscular diseases
  • Subjects with some type of aneurysm diagnosed
  • Subjects with diagnosed extremely high blood pressure
  • Subjects with diagnosed malignant tumors
  • Subjects with diagnosed vertebrobasilar insufficiency
  • Subjects with a diagnosed dermatological condition
  • Subjects diagnosed with epilepsy
  • Pregnant women or with the possibility that they may be

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pulsion Fisioterapia

Madrid, 28028, Spain

Location

Related Publications (1)

  • Gozalo-Pascual R, Gonzalez-Ordi H, Atin-Arratibel MA, Llames-Sanchez J, Alvarez-Melcon AC. Efficacy of the myofascial approach as a manual therapy technique in patients with clinical anxiety: A randomized controlled clinical trial. Complement Ther Clin Pract. 2023 May;51:101753. doi: 10.1016/j.ctcp.2023.101753. Epub 2023 Mar 29.

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Myofascial Release Therapy

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Rodrigo Gozalo Pascual, PT

    Universidad Complutense de Madrid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients will be assigned to two groups: * Experimental group: who will receive myofascial intervention * Control / placebo group: who will receive sham myofascial intervention Neither the participants assigned to the groups nor the evaluators who measure the variables know to which group the subjects belong. Participants will be randomly assigned through the GraphPad software.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized double blind clinical trial controlled with placebo in which neither the participants assigned to the groups nor the evaluators who measure the variables know to which group the subjects belong. To be part of the study, participants must obtain high scores in anxiety (STAI questionnaire). The calculation estimates a sample of 36 participants: 18 for the experimental group and 18 for the placebo group. Participants will be randomly assigned to the experimental group or the placebo group. In addition to anxiety levels before and after treatment, variables such as chronic pain, central sensitization, general health, somatization and depression will be measured.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physical / Manual Therapist (PT, PhD Student), Biomechanics Professor

Study Record Dates

First Submitted

March 25, 2021

First Posted

April 1, 2021

Study Start

April 20, 2021

Primary Completion

July 29, 2022

Study Completion

July 29, 2022

Last Updated

August 2, 2022

Record last verified: 2022-07

Locations